The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Århus County, Denmark

Acta Ophthalmologica Scandinavica

Volumn 82, Issue 4, 2004, Pages 443-448

  Hove, Marianne N ^a   Kristensen, Jette K ^b   Lauritzen, Torsten ^b   Bek, Toke ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Blindness; Diabetic retinopathy; Prevalence; Risk factors; Type 2 diabetes; Visual impairment

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DENMARK; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; EYE PHOTOGRAPHY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LASER COAGULATION; LIPOPROTEIN BLOOD LEVEL; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; PATIENT REFERRAL; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULA EDEMA; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION;

AGED; APOLIPOPROTEINS; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; DENMARK; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GEOGRAPHY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; PREVALENCE; RISK FACTORS; TRIGLYCERIDES; VISION DISORDERS;

EID: 4444366881     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2004.00270.x     Document Type: Article

References (33)

1. Agardh E, Agardh CD & Hansson-Lundblad C (1993): The 5-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med 10: 555-559.
2. Agardh E, Torffvit O & Agardh CD (1989): Putative risk factors associated with retinopathy in patients with diabetes diagnosed at or after 30 years of age. Diabet Med 6: 724-727.
3. Alberti KG & Zimmet PZ (1998): Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15: 539-553.
4. Broadbent DM, Scott JA, Vora JP & Harding SP (1999): Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye 13: 160-165.
5. Chew EY, Klein ML, Ferris FL, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ & Miller D (1996): Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol 114: 1079-1084.
6. Delcourt C, Villatte-Cathelineau B, Vauzelle-Kervroedan F, Cathelineau G & Papoz L (1995): Visual impairment in type 2 diabetic patients. A multicentre study in France. CODIAB-INSERM-ZENECA Pharma Study Group. Acta Ophthalmol Scand 73: 293-298.
7. Eggertsen R, Kalm H & Blohme G (1993): The value of screening for retinopathy and microalbuminuria in patients with type 2 diabetes in primary health care. Scand J Prim Health Care 11: 135-140.
8. de Fine Olivarius N, Nielsen NV & Andreasen AH (2001): Diabetic retinopathy in newly diagnosed middle-aged and elderly diabetic patients. Prevalence and inter-relationship with microalbuminuria and triglycerides. Graefes Arch Clin Exp Ophthalmol 239: 664-672.
9. Henricsson M, Nilsson A, Groop L, Heijl A & Janzon L (1996a): Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycaemic control. Acta Ophthalmol Scand 74: 523-527.
10. Henricsson M, Tyrberg M, Heijl A & Janzon L (1996b): Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme. Acta Ophthalmol Scand 74: 533-538.
11. Jerneld B (1988): Prevalence of diabetic retinopathy. A population study from the Swedish island of Gotland. Acta Ophthalmol Scand (Suppl) 188: 3-32.
12. Jerneld B & Algvere P (1987): Visual acuity in a diabetic population. Acta Ophthalmol (Copenh) 65: 170-177.
13. Kim CH, Park HJ, Park JY, Hong SK, Yoon YH & Lee KU (1998): High serum lipoprotein (a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy. Diabetes Care 21: 2149-215l.
14. Klein R, Klein BE & Moss SE (1984a): Visual impairment in diabetes. Ophthalmology 91: 1-9.
15. Klein R, Klein BE, Moss SE, Davis MD & DeMets DL (1984b): The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526.
16. Klein R, Klein BE, Moss SE, Davis MD & DeMets DL (1984c): The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527-532.
17. Klein R, Sharrett AR, Klein BE et al. (2002): The association of atherosclerosis, vascular risk factors and retinopathy in adults with diabetes: the Atherosclerosis Risk in Communities Study. Ophthalmology 109: 1225-1234.
18. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR & Turner RC (1998): United Kingdom Prospective Diabetes Study 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 116: 297-303.
19. Kristensen JK & Lauritzen T (2002): Polypharmacological treatment of type 2 diabetes in daily clinical practice. A registry-based study in the county of Aarhus. Ugeskr Laeger 164: 5250-5253.
20. Kristensen JK, Sandbaek A, Lassen JF, Bro F & Lauritzen T (2001): Use and validation of public data files for identification of diabetic population in a Danish county. Dan Med Bull 48: 33-37.
21. Kristinsson JK, Stefansson E, Jonasson F, Gislason I & Bjornsson S (1994): Screening for eye disease in type 2 diabetes mellitus. Acta Ophthalmol (Copenh) 72: 341-346.
22. Larsson LI, Alm A, Lithner F, Dahlen G & Bergstrom R (1999): The association of hyperlipidaemia with retinopathy in diabetic patients aged 15-50 years in the county of Umea. Acta Ophthalmol Scand 77: 585-591.
23. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD & Polak BC (2002): Blood pressure, lipids and obesity are associated with retinopathy: the Hoorn Study. Diabetes Care 25: 1320-1325.
24. McKay R, McCarthy CA & Taylor HR (2000): Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project. Br J Ophthalmol 84: 865-870.
25. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM & Newton RW (1997): Adherence to insulin treatment, glycaemic control and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet 350: 1505-1510.
26. Nielsen NV (1982): The prevalence and causes of impaired vision in diabetics. Acta Ophthalmol 60: 677-691.
27. Nielsen NV (1984): Diabetic retinopathy II. The course of retinopathy in diabetics treated with oral hypoglycaemic agents and diet regime alone. A 1-year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Actas Ophthalmol (Copenh) 62: 266-273.
28. Passa P (2002): Diabetes trends in Europe. Diabetes Metab Res Rev 18 (3): 3-8.
29. Poulsen PL, Bek T, Ebbehoj E, Hansen KW & Mogensen CE (1998): 24-h ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients. Diabetologia 41: 105-110.
30. Rodriguez J, Sanchez R, Munoz B, West SK, Broman A, Snyder RW, Klein R & Quigley H (2002): Causes of blindness and visual impairment in a population-based sample of US Hispanics. Ophthalmology 109: 737-743.
31. Sparrow JM, McLeod BK, Smith TD, Birch MK & Rosenthal AR (1993): The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin treated diabetic patients of an English town. Eye 7: 158-163.
32. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE & Matthews DR (2001): UKPDS 50: risk factors for incidence and progression of retinopathy in type 2 diabetes over 6 years from diagnosis. Diabetologia 44: 156-163.
33. UK Prospective Diabetes Study Group 38 (1998): Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 317: 703-713.